Poststroke anxiety and depression: epidemiology, mechanisms, and management strategies - Takeaways - MDSpire

Poststroke anxiety and depression: epidemiology, mechanisms, and management strategies

  • By

  • Yulong Xie

  • Dandan Wang

  • Qing Shi

  • Liping Zhou

  • Tairong Ai

  • May 4, 2026

  • 0 min

Share

  • 1

    Poststroke anxiety and depression (PSAD/PSAnx) significantly impact recovery, quality of life, and long-term prognosis in stroke survivors.

  • 2

    The pathogenesis of PSAD/PSAnx involves neurobiological alterations, cognitive dysfunction, and social environmental factors.

  • 3

    Pharmacological treatments, particularly SSRIs and SNRIs, are essential for managing moderate to severe cases of poststroke mood disorders.

  • 4

    Nonpharmacological interventions, including rehabilitation and psychological therapies, can enhance emotional well-being and adherence to treatment.

  • 5

    Future research should focus on high-quality trials and multimodal interventions to optimize recovery from poststroke mood disorders.

Original Source(s)

Poststroke anxiety and depression: epidemiology, mechanisms, and management strategies

  • by Yulong Xie, Dandan Wang, Qing Shi, Liping Zhou, Tairong Ai

  • May 4, 2026

Related Content

Zack Z. Ramilevich, M.D., Joins Marcus Neuroscience Institute as a General Neurologist

Board-certified neurologist Zack Z. Ramilevich, M.D., has joined Marcus Neuroscience Institute, part of Baptist Health, as a general neurologist.

  • by

  • March 26, 2026

  • 2 min
Newsweek Ranks Two Sentara Hospitals Among the World's Best

Inaugural ranking cites excellence in clinical, customer performance

Theoretical Cost-Effectiveness of PCSK9 Inhibitors in Stroke Due to Intracranial Atherosclerosis